Literature DB >> 3272212

Oesophagogastrectomy using stapling instruments.

D K Kaplan1, R I Whyte, R J Donnelly.   

Abstract

Oesophagogastrectomy is generally considered to be the treatment of choice for resectable tumours of the oesophagus. We have, since January 1980, used stapling instruments whenever possible for the resection and anastomosis. We have also, since June 1983, employed a left thoracotomy approach for lesions of the gastric cardia and mid- or lower oesophagus. One hundred and sixty four patients underwent oesophagogastrectomy during a seven year period, 75 via left thoracotomy. The overall peri-operative mortality was 7.9%. Complications occurred in 17% of patients with anastomotic leakage in 1.8% and anastomotic strictures in 9.7%. Mean hospital stay was 14 days. In the left thoracotomy sub-group mortality was 5%, the complication rate 23%, leak rate 3%, stricture rate 12% and mean hospital stay 13 days.

Entities:  

Mesh:

Year:  1988        PMID: 3272212     DOI: 10.1016/s1010-7940(88)80005-8

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Oesophagogastrectomy in patients over 70.

Authors:  D D Muehrcke; D K Kaplan; R J Donnelly
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

2.  Neoadjuvant chemotherapy with or without neoadjuvant radiotherapy compared with neoadjuvant chemoradiotherapy for esophageal cancer.

Authors:  Yan Zheng; Xianben Liu; Ruixiang Zhang; Zongfei Wang; Haibo Sun; Jianjun Qin; Shilei Liu; Yin Li
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

3.  Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study.

Authors:  Yan Zheng; Yin Li; Xianben Liu; Ruixiang Zhang; Zongfei Wang; Haibo Sun; Shilei Liu
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

4.  A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909).

Authors:  Yan Zheng; Xian-Ben Liu; Hai-Bo Sun; Jinliang Xu; Sining Shen; Yu-Feng Ba; Ming Yan; Zimin Qin; Bao-Xing Liu; Zong-Fei Wang; Shi-Lei Liu; Rui-Xiang Zhang; Pei-Nan Chen; Guang-Hui Liang; Dongfeng Yuan; Zhen-Xuan Li; Qi Liu; Hao-Ran Wang; Hao-Miao Li; Hongwei Lv; Xiaochao Ma; Jianping Zhu; Yong-Kui Yu; Wen-Qun Xing
Journal:  Ann Transl Med       Date:  2021-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.